Join us for this informative VetFolio Voice podcast episode that offers tips for the general practice team who are working with clients whose dogs have received a devastating lymphoma diagnosis. Dr. Cassi, the host of VetFolio Voice, and her guest, Dr. Kimberley Galligher, give a brief overview of canine lymphoma and offer guidelines for providing compassionate communication with these clients. You’ll learn strategies on how to partner with clients and collaborate with referring veterinary oncologists. One of the highlights of this episode is the discussion about the novel oral cancer drug, Laverdia-CA1® (verdinexor tablets), which is the first oral tablet the FDA has conditionally approved to treat lymphoma in dogs. Dr. Cassi and Dr. Galligher probe Laverdia-CA1’s role in the treatment of canine lymphoma in general practice.

Want to earn CE from this podcast?

Be sure to log into VetFolio and take the quiz to qualify for your CE credit!

https://www.vetfolio.com/courses/a-novel-approach-to-treating-canine-lymphoma-for-the-general-practitioner-podcast-quiz